Skip navigation
FACT
Focus on Alternative and Complementary Therapies

Changes after acupuncture in patients with chronic pain conditions – what is clinically important?

Weidenhammer W1, Linde K2, Melchart D1,2
1Centre for Complementary Medicine Research, Internal Medicine II, Technical University Munich,, D–80801 Munich, Germany
2Division of Complementary Medicine, University Hospital, Rämistrasse 100, CH–8091 Zurich, Switzerland

Objective

To investigate the associations of different effect-size measures with global ratings of treatment effect/change in health status, with focus on short- vs. medium-term effects, patients’ vs. physicians’ rating, consistency over different outcomes, and dependency from pain condition.

Materials and methods

This was a secondary analysis of an observational study on acupuncture in 5378 patients (mean (SD) age 54.9 ± 14.7 years; 82.8% female) with chronic headache, low back pain or osteoarthritic pain. Outcomes (at baseline, after last acupuncture session and 6 months after start of treatment) were intensity of pain, days with pain/intake of painkillers, pain-related disability, pain sensation, depression, QOL, functional ability for back pain, and WOMAC for osteoarthritis. Global treatment effect/change in health status was assessed at the end of treatment and 6 months after. Effect sizes were estimated as standardised response means.

Results

Global ratings showed linear fit to effect-size measures for most outcomes. For example, effect sizes of 0.33 and 0.80 were estimated as relevant difference changes for WOMAC score. Patients’ ratings were more sensitive than physicians’ assessment. Standardised mean changes better represented global ratings than percentages with respect to baseline. Similar associations were found for short- and medium-term effects. With the exception of some pain-specific outcomes, associations in pain-related subgroups were comparable.

Conclusion

Definitions of clinically important differences must consider the kind of research question. A lot of factors impact on the appraisal of differences; thus, the determination of general thresholds is not reasonable.

Top | Next: Volume 11 2006»
© Pharmaceutical Press 2009
Accessibility | Terms and Conditions